Search
Close this search box.
    • Small Molecules
      • Discovery
        Development
        Manufacturing
    • Biologics
      • Discovery
        Development & Manufacturing
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery

      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

        Know More
        Know More
    • Industries
    • Emerging Biopharma

      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

        Know More
        Know More
    • Dedicated Centers

      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

        Know More
        Know More
    • Center for Advanced Protein Studies (CAPS)

      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

        Know More
        Know More
    • Investors
      Corporate Governance
  • Careers
Search
Close this search box.
The innovation effect

Future focused

Read Annual Report
Syngene announces second year of STEM scholarship and mentorship program for
women in collaboration with RICH
Read Press Release
Syngene launches platform for rapid, enhanced protein production
Read Press Release
Syngene wins CDMO leadership award 2024

Under the Reliability and Compatibility categories for exceeding customer expectations.

Know More
Syngene commits to science-based targets to reduce greenhouse gas emissions
Know More
Previous slide
Next slide
The innovation effect

Future focused

Read Annual Report
Syngene announces second year of STEM scholarship and mentorship program for women in collaboration with RICH
Read Press Release
Syngene launches platform for rapid, enhanced protein production
Read Press Release
Syngene wins CDMO leadership award 2024

Under the Reliability and Compatibility categories for exceeding customer expectations.

Know More
Syngene commits to science-based targets to reduce greenhouse gas emissions
Know More
Previous slide
Next slide

Who we are

We are an innovation-led contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply.

More
More

What we do

We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements. Our approach enables us to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations.

Discovery

Our Discovery Services span the entire spectrum of early stage research from target …

More
More

Development

Our Development Services encompass activities from pre-clinical to clinical trials…

More
More

Manufacturing

Our Manufacturing services include cGMP-compliant facilities for clinical supplies, registration batches…

More
More

Dedicated Centers

Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support…

More
More

InstaVisit – Visit Syngene virtually

Syngene InstaVisit is an interactive virtual experience designed to give you a 360 degree view of Syngene’s world-class facilities and capabilities. The platform allows you to change your perspective, look around and zoom in as we take you on a guided tour of Syngene’s labs.

View Now
View Now
Visit Syngene virtually with a 360 degree view of Syngene’s world-class facilities and capabilities
0 +

Active Clients

0

Collaborations with top 20 Pharma/Biotech companies

5200 +

Scientists

0

Mn sq. ft. of R&D and manufacturing infrastructure

0 +

Patents 

Latest News

View all
View all

How Indian pharma uses AI to develop faster and cheaper medicines to treat rare diseases

More
News
2nd Jul, 2024

Balancing Innovation with Regulatory Requirements in a CRDMO Setting

More
News
26th Jun, 2024

Resilient Growth Amidst Funding Fluctuations: How Syngene’s Strategic Vision Outperformed the Market

More
News
25th Jun, 2024

Insights

View all
View all

Innovation at Syngene: Translatable models for improving cancer research

Syngene scientists have developed orthotopic and spheroid tumor models, which can help improve translatability and clinical relevance for cancer research.
More

pDNA and mRNA manufacturing in the age of Precision Therapies: The role of CDMOs

Challenges in pDNA manufacturing and why CDMOs are best suited for supplying pDNA for Precision Therapies.
More

Leveraging High Throughput Screening services to accelerate drug discovery and development

The many applications of HTS and how it has evolved beyond lead identification and candidate optimization today.
More

Upcoming events

View all
View all

Bio Asia Taiwan 2024

25th to 28th July
Taiwan

CPHI Korea

27th to 29th August
Seoul, South Korea

3rd Oligo CMC & Analytical Development Summit

27th to 29th August
Boston, USA

PDDP Summit EU

09th to 10th September
Barcelona

Corporate Social Responsibility

To strive towards developing and sustaining healthy and empowered communities by improving the quality of life.
More
More

Governance

Behind consistent growth is good governance

More
More

Careers

Discover a world of opportunities

More
More

Annual Reports

Touching a billon lives through innnovation

More
More

Sign-up for our newsletter

© 2024. Syngene International Limited

Linkedin-in Youtube Facebook-f

Quick links

Business

Get in touch

Other links
Linkedin-in Youtube Facebook-f

© 2024. Syngene International Limited

Download PDF
Download PDF

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details